Journal of Cardiac Surgery · 2016 · 22 citations · 3 references
MedicineCardiologyPharmacotherapyCardiovascular PharmacotherapyNeuropharmacologyPsychopharmacologyHeart FailureMethylene Blue TherapySerotonergic PharmacologySerotonergic SignalingVasoactive MedicationsBlood PressureLeft Ventricular Assist Device TherapyMethylene Blue Rescue TherapyPharmacology Of Serotonergic AgentsSerotonergic MechanismsSerotonin Syndrome ManagementVasoplegic Syndrome TreatmentVentricular Assist Device Support
Methylene blue (MB) has been used for additional blood pressure support in patients who develop severe, refractory vasoplegia; however, MB can induce serotonin syndrome, especially when used in conjunction with other serotonergic agents. We describe a case of serotonin syndrome in a patient who received MB for vasoplegic syndrome after left ventricular assist device implantation and discuss its presentation and management.
3